- Home
- CVS vs DHR Comparison
CVS vs DHR Comparison
Compare CVS & DHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CVS | DHR |
|---|---|---|
| Founded | 1963 | 1969 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail-Drug Stores and Proprietary Stores | Industrial Machinery/Components |
| Sector | Consumer Staples | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 133.6B | 136.7B |
| IPO Year | 1994 | 2007 |
Fundamental Metrics
Financial Performance| Metric | CVS | DHR |
|---|---|---|
| Price | $96.76 | $198.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 18 | 13 |
| Target Price | $94.72 | ★ $241.69 |
| AVG Volume (30 Days) | ★ 7.3M | 5.6M |
| Earning Date | 05-06-2026 | 04-21-2026 |
| Dividend Yield | ★ 3.17% | 0.89% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.61 | 2.68 |
| Revenue | ★ $402,067,000,000.00 | $19,893,000,000.00 |
| Revenue This Year | $2.36 | $5.43 |
| Revenue Next Year | $4.69 | $5.74 |
| P/E Ratio | ★ $21.50 | $74.49 |
| Revenue Growth | 7.85 | ★ 8.53 |
| 52 Week Low | $63.30 | $160.93 |
| 52 Week High | $110.68 | $242.80 |
Technical Indicators
Market Signals| Indicator | CVS | DHR |
|---|---|---|
| Relative Strength Index (RSI) | 39.05 | 55.93 |
| Support Level | $72.65 | $178.87 |
| Resistance Level | $106.15 | $207.37 |
| Average True Range (ATR) | 2.54 | 6.78 |
| MACD | -1.18 | 0.04 |
| Stochastic Oscillator | 37.78 | 76.49 |
Price Performance
Historical ComparisonAbout CVS CVS Health Corporation
CVS Health offers a diverse set of healthcare services. Its roots are in its retail pharmacy operations, where it operates around 9,000 stores primarily in the US. CVS is also a large pharmacy benefit manager (acquired through Caremark), processing about 2 billion adjusted claims annually. It operates a top-tier health insurer (acquired through Aetna) through which it serves about 27 million medical members. The acquisition of Oak Street Health added primary care services to the mix, which could have significant synergies with all existing business lines.
About DHR Danaher Corporation
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.